Metastatic Cancer Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
I
Not yet recruiting
  • Metastatic Cancer
  • +8 more
  • IPH5301 ALONE OR IN COMBINATION WITH CHEMOTHERAPY AND TRASTUZUMAB
  • (no location specified)
2021-12-02
Dec 2, 2021
N
Enrolling by invitation
  • Melanoma
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    2021-12-02
    Dec 2, 2021
    O
    Not yet recruiting
    • Metastatic Cancer
    • +2 more
    • Cleveland, Ohio
      Cleveland Clinic, Case Comprehensive Cancer Center
    2021-11-29
    Nov 29, 2021
    P
    Recruiting
    • Metastatic Cancer
    • +4 more
    • Phoenix, Arizona
    • +8 more
    2021-11-30
    Nov 30, 2021
    U
    Not yet recruiting
    • Metastatic Cancer
    • Palliative
    • Hexoskin Medical System
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    2021-11-29
    Nov 29, 2021
    M
    Recruiting
    • Locally Advanced Carcinoma
    • Metastatic Cancer
    • Next Generation Sequencing
    • Biomarker Monitoring
    • Graz, Austria
      Medical University of Graz
    2021-11-26
    Nov 26, 2021
    U
    Recruiting
    • Metastatic Cancer
    • Breast Cancer
    • Point of service delivery model
    • Kansas City, Kansas
      The University of Kansas Cancer Center, Westwood Campus
    2021-11-23
    Nov 23, 2021
    P
    Not yet recruiting
    • Metastatic Cancer
    • Epithelial Tumor
    • NG-641 in combination with Nivolumab
    • (no location specified)
    2021-11-23
    Nov 23, 2021
    M
    Active, not recruiting
    • Advanced Cancer
    • +2 more
    • Los Angeles, California
    • +11 more
    2021-11-12
    Nov 12, 2021
    A
    Recruiting
    • Metastatic Cancer
    • +2 more
    • ASP9801
    • Tucson, Arizona
    • +18 more
    2021-11-17
    Nov 17, 2021
    I
    Recruiting
    • Solid Tumor
    • +6 more
    • Orange, California
    • +10 more
    2021-11-17
    Nov 17, 2021
    T
    Active, not recruiting
    • Solid Tumor
    • Metastatic Cancer
    • Birmingham, Alabama
    • +3 more
    2021-11-17
    Nov 17, 2021
    C
    Recruiting
    • Pancreatic Ductal Adenocarcinoma
    • +3 more
    • Cholesterol metabolism disruption
    • Quebec city, Quebec, Canada
      CHU de Québec-Université Laval
    2021-11-12
    Nov 12, 2021
    M
    Recruiting
    • Metastatic Cancer
    • +5 more
    • Stereotactic Body Radiotherapy
    • Ipilimumab, Nivolumab, Pembrolizumab or Atezolizumab
    • Hartford, Connecticut
    • +9 more
    2021-11-17
    Nov 17, 2021
    I
    Not yet recruiting
    • Metastatic Cancer
    • Point score prediction tool for 30-day survival
    • Avon, Indiana
    • +4 more
    2021-11-02
    Nov 2, 2021
    S
    Active, not recruiting
    • Metastatic Cancer
    • Solid Tumor
    • Aurora, Colorado
    • +16 more
    2021-11-08
    Nov 8, 2021
    P
    Recruiting
    • Metastatic Cancer
    • Epithelial Tumor
    • NG-641
    • Los Angeles, California
    • +4 more
    2021-11-02
    Nov 2, 2021
    N
    Recruiting
    • Refractory Cancer
    • +6 more
    • SNK01
    • +2 more
    • Santa Monica, California
      Sarcoma Oncology Research Center
    2021-11-08
    Nov 8, 2021
    K
    Recruiting
    • Squamous Cell Carcinoma of Head and Neck
    • +11 more
    • New Haven, Connecticut
    • +13 more
    2021-11-01
    Nov 1, 2021
    T
    Active, not recruiting
    • Neoplasms
    • +6 more
    • Scottsdale, Arizona
    • +7 more
    2021-11-04
    Nov 4, 2021
    T
    Not yet recruiting
    • Hepatocellular Carcinoma
    • Metastatic Cancer
    • Selective Internal Radiation Therapy with QuiremSpheresTM Holmium-166 Microspheres
    • (no location specified)
    2021-10-26
    Oct 26, 2021
    A
    Active, not recruiting
    • Transitional Cell Carcinoma
    • +2 more
    • Nivolumab/Ipilimumab
    • Graz, Austria
    • +26 more
    2021-11-02
    Nov 2, 2021
    B
    Active, not recruiting
    • Lung Cancer
    • Metastatic Cancer
    • Detroit, Michigan
      Barbara Ann Karmanos Cancer Institute
    2021-10-05
    Oct 5, 2021